Evidence map›Paper›PMID 42852373›Full record

ReviewFrontiers in immunology2026

Necro-mosaic: a lesion-aware framework for testing programmed cell-death-associated mechanisms in tuberculosis.

Qing Zhang, De Chang

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Qing ZhangDepartment of Pulmonary and Critical Care Medicine at the Seventh Medical Center Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
De ChangDepartment of Pulmonary and Critical Care Medicine at the Seventh Medical Center Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) can progress despite substantial systemic immune activation, indicating that protection and immunopathology are shaped not only by the magnitude of host responses but also by their organization within individual lesions. TB granulomas are heterogeneous tissue ecosystems in which cellular composition, necrosis, vascular access, extracellular-matrix remodeling, metabolic stress, and local drug exposure vary across lesions and over time. Spatial and single-cell technologies now enable these features to be investigated at increasing resolution; however, spatial or molecular association alone does not establish mechanism, causality, or therapeutic relevance. Here, we propose the Necro-Mosaic framework as a hypothesis-generating, lesion-aware approach for investigating programmed cell death (PCD)-associated processes in TB. The framework is neither a mutually exclusive taxonomy nor a clinical classification system. It considers three non-exclusive, mechanistically framed axes: F-axis, involving ferroptosis-associated lipid-peroxidation injury and membrane damage; P-axis, involving coordinated inflammatory cell-death activity with PANoptosis-like features; and N-axis, involving neutrophil-associated extracellular activity, including NET-associated structures and effector processes. The anatomical distribution, co-occurrence, temporal sequence, and biological consequences of these axis-associated processes remain empirical questions. A single lesion may therefore exhibit one axis-associated pattern, several overlapping patterns, or no interpretable pattern. We distinguish pathway capacity, pathway engagement, and mechanism-specific execution and specify the measurements and controls required to support each level of inference

Indexed as

ApoptosisMycobacterium tuberculosisTuberculosisAnimalsGranulomaHost-Pathogen InteractionsHumansNecrosisferroptosisgranulomahost-directed therapylesion heterogeneityneutrophil extracellular trapsPANoptosisprogrammed cell deathtuberculosis

Identifiers

PMID42852373
PMCPMC13648034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.